Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Michigan Business Tribune.
Press releases published on May 13, 2025
GrowGeneration’s MMI Announces New Luxury Mobile Package & Luggage Storage Solution Designed Exclusively for Waldorf Astoria Hotels
GlobeNewswire
·
May 13, 2025
DENVER, May 13, 2025 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ: GRWG) (“GrowGen” or the “Company”), the nation’s largest specialty hydroponic and organic gardening retailer, today announced the launch of MMI Storage Solutions’ new mobile package and …
UPCX Becomes Official Associate Partner of Formula E Tokyo E-Prix 2025, Advancing Web3 and Sustainable Mobility
GlobeNewswire
·
May 13, 2025
Singapore, May 13, 2025 (GLOBE NEWSWIRE) -- UPCX, a leading blockchain-based open-source payment platform, is thrilled to announce its official sponsorship of the ABB FIA Formula E World Championship Tokyo E-Prix 2025 as an Associate Partner. This landmark …
Apollo Hybrid Funds to Acquire PowerGrid Services from The Sterling Group
GlobeNewswire
·
May 13, 2025
Investment Will Support Leading Provider of Electric Utility Maintenance and Construction Services in its Mission to Address Growing US Power Demand and Needed Grid Improvements HARTSELLE, Ala. and NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Apollo (NYSE: …
Landstar System Reports First Quarter Revenue of $1.153B and Earnings per Share of $0.85 and Announces 11% Increase to Quarterly Dividend
GlobeNewswire
·
May 13, 2025
JACKSONVILLE, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- Landstar System, Inc. (NASDAQ: LSTR) (“Landstar” or the “Company”) today reported basic and diluted earnings per share (“EPS”) of $0.85 in the 2025 first quarter on revenue of $1.153 billion. “The …
Intuitive Machines Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 13, 2025
HOUSTON, May 13, 2025 (GLOBE NEWSWIRE) -- Intuitive Machines, Inc. (Nasdaq: LUNR, “Intuitive Machines,” or the “Company”), a leading space technology and infrastructure services company, today announced its financial results for the first quarter ended …
Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Highlights
GlobeNewswire
·
May 13, 2025
Progress continues in Phase 3 Orbit study of setrusumab in osteogenesis imperfecta (OI) Cash of $62.5 million as of March 31, 2025, expected to fund operations into 2027 LONDON, May 13, 2025 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“ …
Bicara Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 13, 2025
Updated data from ongoing Phase 1/1b trial in 1L R/M HNSCC to be presented at 2025 ASCO Annual Meeting Enrollment ongoing in FORTIFI-HN01, a pivotal Phase 2/3 trial of ficerafusp alfa in 1L R/M HNSCC Strong financial position with approximately $462 …
Caliber Hospitality Development Launches to Pursue Opportunistic and Distressed Hotel Investments
GlobeNewswire
·
May 13, 2025
SCOTTSDALE, Ariz., May 13, 2025 (GLOBE NEWSWIRE) -- Caliber (NASDAQ: CWD), a real estate investor, developer, and manager, today announced the launch of Caliber Hospitality Development, LLC (“CHD”), a joint venture between Caliber and GIA Hospitality, LLC …
Knight to Present at the 2025 RBC Capital Markets Global Healthcare Conference in New York City
GlobeNewswire
·
May 13, 2025
MONTREAL, May 13, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Executive Officer, is scheduled to participate in a …
Maze Therapeutics to Participate in the 3rd Annual H.C. Wainwright BioConnect Investor Conference
GlobeNewswire
·
May 13, 2025
SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with renal, metabolic and cardiovascular diseases, …
UNISYNC Reports Q2 Fiscal 2025 Operating Results Showing Continued Improvement in Profitability
GlobeNewswire
·
May 13, 2025
TORONTO, May 13, 2025 (GLOBE NEWSWIRE) -- Unisync Corp. (“Unisync”) (TSX:"UNI") (OTC:“USYNF”) is pleased to report a net income before tax of $1.0 million($0.05/share) and an Adjusted EBITDA of $3.1 million($0.16/share) on revenues of $24.5 million for the …
Atomic Minerals Announces Share Exchange Agreement to Acquire Quebec Mineral Claims
GlobeNewswire
·
May 13, 2025
Vancouver, British Columbia, May 13, 2025 (GLOBE NEWSWIRE) -- Atomic Minerals Corporation ("Atomic Minerals" or the "Company") (TSX Venture: ATOM) is pleased to announce that it has entered into a share exchange agreement (the “Agreement”) with the …
Knight présentera à la conférence sur la santé internationale de 2025 de RBC Marchés des Capitaux à New York
GlobeNewswire
·
May 13, 2025
MONTRÉAL, 13 mai 2025 (GLOBE NEWSWIRE) -- Thérapeutique Knight inc. (TSX : GUD) (« Knight »), société pharmaceutique spécialisée panaméricaine (ex-ÉU), a annoncé aujourd'hui que Samira Sakhia, présidente et chef de la direction, participera à une …
American Tungsten Corp. To Host Management Update Webinar
GlobeNewswire
·
May 13, 2025
Vancouver, BC, May 13, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) announces that the Company’s CEO, Ali Haji will host a webinar to give an overview of the company’s recent …
Nayax Reports First Quarter 2025 Results
GlobeNewswire
·
May 13, 2025
Expands global customer base to more than 100,000 Total revenue of $81.1 million, recurring revenue growth of 35% YoY Gross Margin grew significantly to 49% Net income of $7.2 million with Adjusted EBITDA of $9.7 million (1) Company reaffirms full year …
XOMA Royalty Reports First Quarter 2025 Financial Results and Highlights Business Achievements
GlobeNewswire
·
May 13, 2025
Pipeline advancements: The Marketing Authorization Application (MAA) for Day One Biopharmaceuticals and Ipsen’s tovorafenib was accepted for review by the European Marketing Authority (EMA) and Takeda initiated its Phase 3 trial exploring mezagitamab for …
Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates
GlobeNewswire
·
May 13, 2025
BURLINGTON, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today reported business updates …
Stardust Power Confirms No Industrial Wastewater Permit Required for Oklahoma Lithium Facility
GlobeNewswire
·
May 13, 2025
GREENWICH, Conn., May 13, 2025 (GLOBE NEWSWIRE) -- Stardust Power Inc. ("Stardust Power" or the "Company"), an American developer of battery-grade lithium products, today announced a significant update to its permitting process. Following a determination …
Purple Pepe listed on major crypto exchanges, enters US real estate market
GlobeNewswire
·
May 13, 2025
WEST PALM BEACH, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- The viral crypto project Purple Pepe (PURPE) continues its rise with multiple new exchange listings and a historic leap into real-world utility. Less than a year since its launch, the community-driven …
AquaSculpt Reviews and Complaints: Is Aqua Sculpt’s Top Weight Loss Secrets Too Good to Believe? (Shocking Results!)
GlobeNewswire
·
May 13, 2025
AUSTIN, Texas, May 13, 2025 (GLOBE NEWSWIRE) -- AquaSculpt is among the most often discussed natural supplements for weight loss in 2025—and it's not hard to understand why. Search engines with searches like "Aqua Sculpt Pills," "Aqua Sculpt Weight Loss …